CiteULike
Facebook
Mendeley
Twitter
This article is- freely available
- re-usable
Viruses 2010, 2(4), 1002-1007; doi:10.3390/v2041002
Editorial
Novel Viral Vector Systems for Gene Therapy
Quantitative Biosciences Institute, Department of Chemical Engineering, University of California, Berkeley, CA 94720, USA
Received: 13 April 2010 / Accepted: 13 April 2010 / Published: 14 April 2010
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
Download PDF Full-Text [36 KB, uploaded 14 April 2010 11:34 CEST]
Abstract: Over the last three decades, interest in the field of gene therapy seems to have fluctuated between hot and cold. Encouraging pre-clinical and clinical data has demonstrated the potential of genetic therapies and yet setbacks in clinical trials have cast doubts in some minds over the clinical future of gene therapy [1-3]. In the last two years, a number of studies have demonstrated therapeutic benefits in clinical trials aimed towards specific monogenetic disorders [4-6], and this has brought renewed optimism to the field. [...]
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Stone, D. Novel Viral Vector Systems for Gene Therapy. Viruses 2010, 2, 1002-1007.
AMA StyleStone D. Novel Viral Vector Systems for Gene Therapy. Viruses. 2010; 2(4):1002-1007.
Chicago/Turabian StyleStone, Daniel. 2010. "Novel Viral Vector Systems for Gene Therapy." Viruses 2, no. 4: 1002-1007.